Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
On December 16, 2015, the Food and Drug Administration (FDA) in the United States approved sugammadex (Bridion, Merck and Co), a modified gamma-cyclodextrin, to be used as a reversal agent. It is a first and unique selective nondepolarizing steroidal muscle relaxant (NDSMR) binding agent with a grea...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wiley
2020-01-01
|
| Colección: | Case Reports in Anesthesiology |
| Acceso en línea: | http://dx.doi.org/10.1155/2020/8767195 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|